← Back
$APUS All transactions

Apimeds Pharmaceuticals US, Inc.

A

$ Value

$0

Shares

347,279

Price

$0

Filed

May 20

Insider

Name

Emerson Erik C.

Title

Chief Executive Officer

CIK

0001710496

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-16

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

347,279

Footnotes

Forty percent (40%) of the options vested immediately upon grant, and the remainder will vest in three equal annual installments beginning on 05/16/2026. The reporting person has agreed not to sell any shares underlying the options, even if exercised, for a period of three years from the date of grant.

Filing Info

Accession No.

0001474506-25-000099

Form Type

4

Issuer CIK

0001894525

Emerson Erik C.'s History

Date Ticker Type Value
2025-10-15 APUS A $0
2025-05-16 APUS A $0
2025-05-16 APUS A $0

Other Insiders at APUS (90d)

No other insider activity at this issuer in the last 90 days.